Page last updated: 2024-10-18

iodine and Glioma

iodine has been researched along with Glioma in 9 studies

Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"Therapy monitoring of glioma after stereotactic iodine-125 brachytherapy (SBT) remains challenging because posttherapeutic changes in magnetic resonance imaging can mimic tumor progression."7.79[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma. ( Bartenstein, P; Belka, C; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Schwarz, SB; Suchorska, B, 2013)
"To augment the therapeutic efficacy of BNCT, we used transferrin-conjugated polyethylene glycol (PEG) (TF-PEG) liposome encapsulating sodium borocaptate and Iomeprol, an iodine contrast agent, with intratumoral convection-enhanced delivery (CED) in a rat glioma tumor model."7.77Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. ( Doi, A; Hiramatsu, R; Ikeda, N; Kasaoka, S; Kawabata, S; Kuroiwa, T; Maruyama, K; Miyata, S; Miyatake, S; Yamashita, T, 2011)
"Gliomas and other brain tumors have evaded durable therapies, ultimately causing about 20% of all cancer deaths."5.51Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy. ( Hainfeld, JF; Panchal, R; Ridwan, SM; Slatkin, DN; Smilowitz, HM; Stanishevskiy, Y, 2019)
"Therapy monitoring of glioma after stereotactic iodine-125 brachytherapy (SBT) remains challenging because posttherapeutic changes in magnetic resonance imaging can mimic tumor progression."3.79[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma. ( Bartenstein, P; Belka, C; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Schwarz, SB; Suchorska, B, 2013)
"To augment the therapeutic efficacy of BNCT, we used transferrin-conjugated polyethylene glycol (PEG) (TF-PEG) liposome encapsulating sodium borocaptate and Iomeprol, an iodine contrast agent, with intratumoral convection-enhanced delivery (CED) in a rat glioma tumor model."3.77Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. ( Doi, A; Hiramatsu, R; Ikeda, N; Kasaoka, S; Kawabata, S; Kuroiwa, T; Maruyama, K; Miyata, S; Miyatake, S; Yamashita, T, 2011)
" Two complimentary SSR approaches have been successfully developed in the past 5 years in our team, and may be promising in high-grade glioma management: iodine-enhanced SSR, with an iodinated contrast agent; and Pt-enhanced SSR; a concomitant radio-chemotherapy treatment with locoregional injection of platinated chemotherapy drugs."3.74Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment. ( Adam, JF; Balosso, J; Biston, MC; Boudou, C; Charvet, AM; Elleaume, H; Estève, F; Rousseau, J, 2008)
"Comparison of different contrast dosages in adult patients with malignant gliomas studied by computed tomography indicates that 28-42 g of iodine is required for clinically diagnostic results."3.66Optimal contrast dosage in cranial computed tomography. ( Enzmann, DR; Newton, TH; Norman, D, 1978)
"Gliomas and other brain tumors have evaded durable therapies, ultimately causing about 20% of all cancer deaths."1.51Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy. ( Hainfeld, JF; Panchal, R; Ridwan, SM; Slatkin, DN; Smilowitz, HM; Stanishevskiy, Y, 2019)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hainfeld, JF1
Ridwan, SM1
Stanishevskiy, Y1
Panchal, R1
Slatkin, DN1
Smilowitz, HM1
Jansen, NL1
Suchorska, B1
Schwarz, SB1
Eigenbrod, S1
Lutz, J1
Graute, V1
Bartenstein, P1
Belka, C1
Kreth, FW1
la Fougère, C1
Miyata, S1
Kawabata, S1
Hiramatsu, R1
Doi, A1
Ikeda, N1
Yamashita, T1
Kuroiwa, T1
Kasaoka, S1
Maruyama, K1
Miyatake, S1
FEINDEL, W1
YAMAMOTO, YL1
MCRAE, DL1
ZANELLI, J1
Adam, JF2
Elleaume, H3
Joubert, A1
Biston, MC2
Charvet, AM3
Balosso, J2
Le Bas, JF2
Estève, F3
Rousseau, J1
Boudou, C1
Le Duc, G1
Bertrand, B1
Corde, S1
Farion, R1
Lefaix, JL1
Leplat, JJ1
Berkvens, P1
Berruyer, G1
Brochard, T1
Dabin, Y1
Draperi, A1
Fiedler, S1
Nemoz, C1
Perez, M1
Renier, M1
Suortti, P1
Thomlinson, W1
Norman, D2
Enzmann, DR1
Newton, TH2
Stevens, EA1
Wing, SD1
Levin, V1

Other Studies

9 other studies available for iodine and Glioma

ArticleYear
Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy.
    Scientific reports, 2019, 03-14, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Doxorubicin; F

2019
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma.
    Molecular imaging, 2013, Volume: 12, Issue:3

    Topics: Brachytherapy; Disease-Free Survival; Glioma; Humans; Iodine; Magnetic Resonance Imaging; Positron-E

2013
Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
    Neurosurgery, 2011, Volume: 68, Issue:5

    Topics: Animals; Borohydrides; Boron Neutron Capture Therapy; Brain Neoplasms; Contrast Media; Drug Delivery

2011
CONTOUR BRAIN SCANNING WITH IODINE AND MERCURY COMPOUNDS FOR DETECTION OF INTRACRANIAL TUMORS.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1964, Volume: 92

    Topics: Arsenicals; Bismuth; Brain; Brain Neoplasms; Chlormerodrin; Diuretics; Glioma; Hemangiosarcoma; Iodi

1964
Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas.
    International journal of radiation oncology, biology, physics, 2003, Dec-01, Volume: 57, Issue:5

    Topics: Algorithms; Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Glioma; Iodine; Male; Radiot

2003
Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.
    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2008, Volume: 24, Issue:2

    Topics: Animals; Biophysical Phenomena; Biophysics; Brain Neoplasms; Contrast Media; Glioma; Humans; Idoxuri

2008
In vivo K-edge imaging with synchrotron radiation.
    Cellular and molecular biology (Noisy-le-Grand, France), 2000, Volume: 46, Issue:6

    Topics: Animals; Brain Neoplasms; Contrast Media; Coronary Angiography; Europe; Gadolinium; Glioma; Humans;

2000
Optimal contrast dosage in cranial computed tomography.
    AJR. American journal of roentgenology, 1978, Volume: 131, Issue:4

    Topics: Brain Neoplasms; Contrast Media; Glioma; Humans; Injections, Intravenous; Iodine; Tomography, X-Ray

1978
Quantitative aspects of contrast enhancement in cranial computed tomography.
    Radiology, 1978, Volume: 129, Issue:3

    Topics: Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Glioma; Humans; Injections, Intravenous; Iodin

1978